Patent Applications published on Feb 13, 2025 - page 3

#601
US20250049547A1
Human necessities

DENTAL CERAMIC OXIDE PRE-SINTERED BODY HAVING EXCELLENT MACHINABILITY AND PRODUCTION METHOD FOR SAME

#602
US20250049548A1
Human necessities

PERSONAL CARE DEVICE

#603
US20250049549A1
Human necessities

ADAPTABLE MOUTHPIECE ASSEMBLY FOR TOOTH CLEANING

#604
US20250049550A1
Human necessities

VETERINARY SYRINGE

#605
US20250049551A1
Human necessities

GLUTEAL IMPLANTS AND IMPLANT SYSTEMS

#606
US20250049552A1
Human necessities

LAYERED MATERIALS FOR IMPLANTS

#607
US20250049553A1
Human necessities

IMPLANT DELIVERY SYSTEM AND METHOD

#608
US20250049554A1
Human necessities

DUAL HOOP LOW PROFILE EMBOLIC PROTECTION DEVICE AND SYSTEM

#609
US20250049555A1
Human necessities

STENT, METHOD FOR MANUFACTURING STENT, AND METHOD FOR SECURING AIR FLOW BY RELIEVING STENOSIS OF RESPIRATORY ORGAN

#610
US20250049556A1
Human necessities

Biliary Stents and Methods

#611
US20250049557A1
Human necessities

Aortic ARCH Baroreceptor Implants for Treatment of Hypertension

#612
US20250049558A1
Human necessities

CONSTRAINT ARRANGEMENT FOR A STENT-GRAFT LOADED ONTO A DELIVERY SYSTEM

#613
US20250049559A1
Human necessities

SOFT TISSUE REPAIR ALLOGRAFTS AND METHODS FOR PREPARING SAME

#614
US20250049560A1
Human necessities

Implant System and Method for Producing an Implant System

#615
US20250049561A1
Human necessities

ACCOMMODATING INTRAOCULAR LENS

#616
US20250049562A1
Human necessities

STENT SEALS AND METHOD OF PRODUCTION

#617
US20250049563A1
Human necessities

Valve Leaflet Attachment in Collapsible Prosthetic Valves

#618
US20250049564A1
Human necessities

DEVICES, SYSTEMS AND METHODS FOR IMPROVING RECAPTURE OF PROSTHTIC HEART VALVE DEVICE WITH STENT FRAME HAVING VALVE SUPPORT WITH INWARDLY STENT CELLS

#619
US20250049565A1
Human necessities

Prosthetic Heart Valves

#620
US20250049566A1
Human necessities

Stent Designs For Prosthetic Heart Valves

#621
US20250049567A1
Human necessities

Valve Replacement Devices and Methods

#622
US20250049568A1
Human necessities

MECHANICALLY EXPANDABLE PROSTHETIC HEART VALVE AND DELIVERY APPARATUS

#623
US20250049569A1
Human necessities

TRANSCATHETER VALVE DELIVERY SYSTEM WITH IMPROVED LOADING AND DEPLOYMENT

#624
US20250049570A1
Human necessities

STEERABLE DELIVERY SYSTEM FOR REPLACEMENT HEART VALVE

#625
US20250049571A1
Human necessities

HEART VALVE SEALING DEVICES AND DELIVERY DEVICES THEREFOR

#626
US20250049572A1
Human necessities

VALVULAR INSUFFICIENCY REPAIR DEVICE AND METHOD

#627
US20250049573A1
Human necessities

LOW-PROFILE INTERCRANIAL DEVICE

#628
US20250049574A1
Human necessities

POROUS COMPOSITE CONNECTION STRUCTURE CAPABLE OF SENSING DETECTION AND MEDICINE PREPARATION, METHOD, AND PROSTHESIS

#629
US20250049575A1
Human necessities

ARTIFICIAL INTERVERTEBRAL DISC WITH LOWER HEIGHT

#630
US20250049576A1
Human necessities

HIP JOINT DEVICE AND METHOD

#631
US20250049577A1
Human necessities

SYSTEM FOR PERFORMING POSTERIOR SPINAL ARTHRODESIS AT A FACET JOINT

#632
US20250049578A1
Human necessities

FACET FIXATION SYSTEMS AND METHOD

#633
US20250049579A1
Human necessities

Expandable Interbody Device

#634
US20250049580A1
Human necessities

MODULAR SUPPORT CAGE

#635 ✅ Patent 12,303,402 granted on 2025-05-20
US20250049581A1
Human necessities

Spinal interbody fusion device

#636
US20250049582A1
Human necessities

EXPANDABLE INTERVERTEBRAL CAGE

#637
US20250049583A1
Human necessities

Universal Lateral Pivoting Handle

#638
US20250049584A1
Human necessities

INTERBODY TOOL, SYSTEMS, AND METHODS

#639
US20250049585A1
Human necessities

A MODULE-WISE POSTURE CORRECTION MASTECTOMY BRA WITH THERMAL COMFORT AND METHOD OF MAKING THEREOF

#640
US20250049586A1
Human necessities

ACTUATOR AND ORTHOPEDIC TECHNICAL JOINT DEVICE, AND METHOD FOR CONTROLLING SAME

#641
US20250049587A1
Human necessities

INTERRUPTING DEVICE AND COUPLING DEVICE

#642
US20250049588A1
Human necessities

MULTIMODAL HINGE JOINT SYSTEM FOR PROSTHESIS OR ORTHOSIS

#643
US20250049589A1
Human necessities

ORTHOPAEDIC DEVICE AND METHOD FOR PRODUCING SAME

#644
US20250049590A1
Human necessities

ARTIFICIAL KNEE JOINT, AND METHOD FOR CONTROLLING SAME

#645
US20250049591A1
Human necessities

METHOD AND SYSTEM FOR DESIGNING A STENT

#646
US20250049592A1 ⚡
Human necessities

OCCLUSIVE DEVICE

#647
US20250049593A1
Human necessities

Stent and Stent Delivery Device

#648
US20250049594A1
Human necessities

BRANCH STENT

#649
US20250049595A1
Human necessities

ZOTAROLIMUS-ROSUVASTATIN ELUTING BIODEGRADABLE STENT

#650
US20250049596A1
Human necessities

NON-VASCULAR DRUG-ELUTING STENT

#651 ✅ Patent 12,303,412 granted on 2025-05-20
US20250049597A1
Human necessities

Orientable implantable device and method

#652
US20250049598A1
Human necessities

SYSTEMS AND METHODS FOR TREATING AN AORTIC TEAR OR DISSECTION

#653
US20250049599A1
Human necessities

STENTS WITH LINER FACILITATING STENT REMOVAL AND METHODS OF USE

#654
US20250049600A1
Human necessities

DELIVERY SYSTEM

#655
US20250049601A1
Human necessities

Delivery Catheter and Methods of Delivery for Aortic ARCH Baroreceptor Hypertension Implants

#656
US20250049602A1
Human necessities

ELECTRIC TASTE DEVICE

#657
US20250049603A1
Human necessities

CUSTOMIZED WEARABLE WITH INTEGRATED PATHWAYS AND/OR INTERCONNECTS

#658
US20250049604A1
Human necessities

CUSTOMIZED ORTHOSIS WITH INTERWOVEN INTEGRATED COMPONENTS

#659
US20250049605A1
Human necessities

ANGULAR DIGITAL ORTHOSIS FOR LOSS OF DISTAL JOINT EXTENSION

#660
US20250049606A1
Human necessities

INSERT WITH VISCOUS FILLER FOR ENDOSCOPY SUPPORT

#661
US20250049607A1
Human necessities

Conforming Rigid Cast, Brace and Splint Comprising a Curable Polymeric Material

#662
US20250049608A1
Human necessities

Design of Disposable Urine Male pads

#663
US20250049609A1
Human necessities

IMPLANTABLE MEDICAL DEVICES AND METHODS OF USE

#664
US20250049610A1
Human necessities

Ocular Device and Drug Delivery System, With Case

#665
US20250049611A1
Human necessities

SYSTEMS AND METHODS FOR AFFECTING THE BIOMECHANICAL PROPERTIES OF CONNECTIVE TISSUE

#666
US20250049612A1
Human necessities

A DEVICE FOR OPENING AN EUSTACHIAN TUBE OF A PATIENT

#667
US20250049613A1
Human necessities

NEGATIVE PRESSURE WOUND THERAPY DRESSING WITH A SLITTED FOAM LAYER

#668
US20250049614A1
Human necessities

ATRAUMATIC ABSORBENT WOUND DRESSING

#669
US20250049615A1
Human necessities

QUICK APPLICATION OF VENTED TOTAL CONTACT CAST

#670
US20250049616A1
Human necessities

Diaper Guard Device

#671
US20250049617A1
Human necessities

ABSORBENT ARTICLES WITH LOW VOID VOLUME

#672
US20250049618A1
Human necessities

ABSORBENT PAD FOR A GARMENT

#673
US20250049619A1
Human necessities

EXERCISE APPARATUS FOR USE WITH A WHEELCHAIR FOR EXERCISING LOWER LIMB

#674
US20250049620A1
Human necessities

MULTI-WHEELED WHEELCHAIR

#675
US20250049621A1
Human necessities

Patient Support Apparatus For Removably Retaining Differently-Sized Portable Electronic Devices

#676
US20250049622A1
Human necessities

Patient Support

#677
US20250049623A1
Human necessities

BIODEGRADABLE PATIENT LATERIAL TRANSFER SUPPORT SURFACE AND METHOD OF MAKING

#678
US20250049624A1
Human necessities

Operating table and supporting structure

#679
US20250049625A1
Human necessities

SENSORY SUBSTITUTION DEVICES

#680
US20250049626A1
Human necessities

WALL MOUNTED BACK TREATMENT APPARATUS

#681
US20250049627A1
Human necessities

NEGATIVE-PRESSURE MASSAGE CUP

#682
US20250049628A1
Human necessities

AIR PRESSURE ADJUSTING DEVICE, AIR PRESSURE MASSAGER THEREOF AND METHOD FOR CONTROLLING AIR PRESSURE MASSAGER

#683
US20250049629A1
Human necessities

FLEXIBLE END EFFECTORS WITH AN APERTURE

#684
US20250049630A1
Human necessities

Haptic Therapy to Reduce Negative Effects of Neurological Disorders

#685
US20250049631A1
Human necessities

SYSTEMS AND METHODS FOR VIBRATION ANESTHESIA

#686
US20250049632A1
Human necessities

Cameras for Emergency Rescue

#687
US20250049633A1
Human necessities

CPR GURNEY

#688
US20250049634A1
Human necessities

BLISTER CARD

#689
US20250049635A1
Human necessities

AMMONIUM SULFATE TREATED SYRINGE FOR INCREASED PHARMACEUTICAL COMPOSITION STABILITY

#690
US20250049636A1
Human necessities

COLLECTION KIT AND COLLECTION METHOD

#691
US20250049637A1
Human necessities

Medical Containers And System Components With Non-Dehp Plasticizers For Storing Red Blood Cell Products, Plasma And Platelets

#692
US20250049638A1
Human necessities

MEDICATION MIXING AND LOADING APPARATUS

#693
US20250049639A1
Human necessities

DISPENSING DEVICE FOR MEDICAMENTS COMPRISING A DOSE SELECTION AND DOSE SEPARATION MECHANISM

#694
US20250049640A1
Human necessities

MEDICATION APPARATUS

#695
US20250049641A1
Human necessities

PILL DISPENSING SYSTEM AND METHOD

#696
US20250049642A1
Human necessities

A Reversibly Attachable Teething Aid

#697
US20250049643A1
Human necessities

PACIFIER RETENTION APPARATUS

#698 ✅ Patent 12,329,833 granted on 2025-06-17
US20250049644A1
Human necessities

Dental Compositions

#699
US20250049645A1
Human necessities

COMPOSITION AND METHOD FOR PRODUCING SAME

#700
US20250049646A1
Human necessities

SOLID POWDER COSMETIC PRODUCT

#701 ✅ Patent 12,220,468 granted on 2025-02-11
US20250049647A1
Human necessities

Atomic Scale Topical Composition with Enhanced Interstitial Cellular Uptake for Increased Moisturizing, Fluidity, Antioxidant and Radiation Protection, Antimicrobial Cleansing and Therapeutics for Optimal Dermal Integrity and Homeostasis.

#702
US20250049648A1
Human necessities

USE OF BISMUTH OXYCARBONATE PARTICLES FOR FILTERING ULTRAVIOLET RADIATION

#703
US20250049649A1
Human necessities

AQUEOUS LIQUID COSMETIC MATERIAL

#704 ✅ Patent 12,290,579 granted on 2025-05-06
US20250049650A1
Human necessities

Effect pigments having a reflective core and semiconductor layers

#705
US20250049651A1
Human necessities

TWO-PHASE MAKE-UP REMOVER

#706
US20250049652A1
Human necessities

AQUEOUS DISPERSION AND COSMETIC

#707
US20250049653A1
Human necessities

NON-STICKY SMOOTH STABLE COMPOSITION

#708
US20250049654A1
Human necessities

COSMETIC COMPOSITION

#709
US20250049655A1
Human necessities

OIL-IN-WATER EMULSIFIED COSMETIC COMPOSITION

#710
US20250049656A1
Human necessities

COMPOSITION FOR LIGHTENING KERATIN FIBRES AND PROCESS FOR LIGHTENING KERATIN FIBRES USING THIS COMPOSITION

#711
US20250049657A1
Human necessities

PROCESS FOR LIGHTENING OR FOR SIMULTANEOUSLY BLEACHING AND DYEING KERATIN FIBRES

#712
US20250049658A1
Human necessities

Process For Whitening Teeth And Composition and Kit Therefor

#713
US20250049659A1
Human necessities

ORAL COMPOSITIONS AND METHODS OF REDUCING ORAL MALODOR

#714
US20250049660A1
Human necessities

ENOL ETHER PROPERFUME

#715
US20250049661A1
Human necessities

FRAGRANCE COMPOSITIONS INCLUDING GAS FERMENTED ETHANOL AND METHODS OF MAKING

#716
US20250049662A1
Human necessities

AQUEOUS COSMETIC COMPOSITION COMPRISING VANILLIN OR ONE OF ITS DERIVATIVES, A SPECIFIC SEQUESTERING AGENT, AND POSSIBLY AT LEAST ONE ADDITIONAL ANTIMICROBIAL

#717
US20250049663A1
Human necessities

SUNSCREEN OR DAILY CARE COMPOSITION COMPRISING BIS-ETHYLHEXYLOXYPHENOL METHOXYPHENYL TRIAZINE

#718
US20250049664A1
Human necessities

SKIN EXTERNAL APPLICATION COMPOSITION FOR SKIN BARRIER STRENGTHENING OR SKIN MOISTURIZING CONTAINING DEHYDROABIETIC ACID

#719
US20250049665A1
Human necessities

ANTI-IMPERFECTION AQUEOUS MAKEUP REMOVING COMPOSITION

#720
US20250049666A1
Human necessities

LIQUID COMPOSITION HAVING ENHANCED ANTIMICROBIAL ACTIVITY

#721
US20250049667A1
Human necessities

SUNSCREEN OR DAILY CARE COMPOSITION COMPRISING BIS-ETHYLHEXYLOXYPHENOL METHOXYPHENYL TRIAZINE

#722
US20250049668A1
Human necessities

COSMETIC COMPOSITIONS AND METHODS OF USING THE SAME

#723
US20250049669A1
Human necessities

COMPOSITION COMPRISING A SPECIFIC OXIDATION DYE PRECURSOR AND TWO SPECIFIC ACIDS

#724
US20250049670A1
Human necessities

COMPOSITION COMPRISING A PARTICULAR OXIDATION DYE PRECURSOR, A PARTICULAR AMINO SILICONE AND A POLYOL

#725
US20250049671A1
Human necessities

COMPOSITION COMPRISING A PARTICULAR OXIDATION DYE PRECURSOR AND A PARTICULAR AMINO SILICONE

#726
US20250049672A1
Human necessities

COMPOSITIONS AND METHODS FOR HAIR

#727
US20250049673A1
Human necessities

HAIR CONDITIONING COMPOSITION FOR IMPROVED DEPOSITION

#728
US20250049674A1
Human necessities

COSMETIC OR DERMATOLOGICAL COMPOSITION COMPRISING AT LEAST A MEROCYANINE AND A HYDROTROPE

#729
US20250049675A1
Human necessities

CLEANING COMPOSITION CONTAINING SURFACTANT SYSTEM AND ITS APPLICATION

#730
US20250049676A1
Human necessities

ANTIMICROBIAL SYSTEM WITH INDOLE ALKALOID AND PHENOLIC ACID AND COMPOSITIONS COMPRISING THEM

#731
US20250049677A1
Human necessities

Oxa-Macrocyclic Musk as Fragrance Compounds

#732
US20250049678A1
Human necessities

COMPOUNDS ATTACHABLE TO SKIN

#733
US20250049679A1
Human necessities

FORMULATIONS OF ERIODICTYOL

#734
US20250049680A1
Human necessities

COMPOSITIONS AND METHODS FOR TREATING DENTIN CARIES

#735
US20250049681A1
Human necessities

Metal Salt Compositions

#736
US20250049682A1
Human necessities

METHODS FOR ACTIVATION AND PREPARATION OF KERATIN FIBER COATINGS, PREFERABLY COLOR COATINGS

#737
US20250049683A1
Human necessities

COMPOSITIONS AND METHODS FOR INHIBITING HAIR GROWTH

#738
US20250049684A1
Human necessities

COLLAGEN CREAM FORMULATIONS AND METHODS OF USE THEREOF

#739
US20250049685A1
Human necessities

COLLAGEN LOTION FORMULATIONS AND METHODS OF USE THEREOF

#740
US20250049686A1
Human necessities

COLLAGEN SERUM FORMULATIONS AND METHODS OF USE THEREOF

#741
US20250049687A1
Human necessities

A COMPOSITION COMPRISING POLYMERS

#742
US20250049688A1
Human necessities

COMPOSITION FOR COSMETIC USE

#743
US20250049689A1
Human necessities

COMBINATION OF A HIGH MOLECULAR WEIGHT CROSS-LINKED HYALURONIC ACID AND A LOW MOLECULAR WEIGHT NON-CROSS-LINKED HYALURONIC ACID

#744
US20250049690A1
Human necessities

COMPOSITION COMPRISING HYALURONIC ACID-BASED POLYION COMPLEX PARTICLE AND SURFACTANT

#745
US20250049691A1
Human necessities

COSMETIC COMPOSITION COMPRISING A PARTICULATE CELLULOSIC COMPOUND, HYDROPHOBIC SILICA AEROGEL PARTICLES, AND A SEMICRYSTALLINE POLYMER

#746
US20250049692A1
Human necessities

ANTIPERSPIRANT COMPOSITION

#747
US20250049693A1
Human necessities

METHOD FOR AMPLIFYING EXPRESSION OF TRANSPORTER-RELATED GENE IN EPIDERMAL CELLS

#748
US20250049694A1
Human necessities

COMPOSITION COMPRISING TWO PARTICULAR OXIDATION DYE PRECURSORS AND A PARTICULAR AMINO SILICONE

#749
US20250049695A1
Human necessities

SURFACE-COATED PARTICLES

#750
US20250049696A1
Human necessities

PHOTODIMERIZABLE POLYMERS COMPRISING AT LEAST ONE POLYOXYALKYLENE GROUP, COMPOSITION COMPRISING SAME AND COSMETIC TREATMENT PROCESS

#751
US20250049697A1
Human necessities

NATURAL OIL-BASED PETROLATUM AND METHOD OF MAKING SAME

#752
US20250049698A1
Human necessities

BIOACTIVE SERUM FRACTIONS FROM FRESH ROSE FLOWERS AND METHODS FOR THEIR PREPARATION AND USES

#753
US20250049699A1
Human necessities

COSMETIC COMPOSITION FOR PREVENTION OR IMPROVEMENT OF INFLAMMATORY SKIN DISEASES COMPRISING STRAIN OF GENUS CUTIBACTERIUM

#754
US20250049700A1
Human necessities

Wound-Cleansing Method

#755
US20250049701A1
Human necessities

SILK-BASED ARTICLES HAVING VARIABLE ACTIVE AGENT RELEASE RATES

#756
US20250049702A1
Human necessities

INTRANASAL DELIVERY OF CANNABIDIOL TO TREAT CENTRAL NERVOUS SYSTEM DISORDERS

#757
US20250049703A1
Human necessities

METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF RETINAL CAPILLARY NON-PERFUSION

#758
US20250049704A1
Human necessities

HYDROCORTISONE ORAL LIQUID FORMULATIONS

#759
US20250049705A1
Human necessities

PHARMACEUTICAL COMPOSITION COMPRISING TIGECYCLINE

#760
US20250049706A1
Human necessities

MAGNETIC FERRITIC NANOCOMPOSITE

#761
US20250049707A1
Human necessities

INDIVIDUALIZED SOLID DOSAGE PRODUCTS AND A SYSTEM AND METHOD FOR THE GLOBALLY INTEGRATED PHARMACEUTICAL MANUFACTURING AND ITS MONITORING THEREOF

#762
US20250049708A1
Human necessities

A TOPICAL GEL FORMULATION FOR SKIN AND MOUTH DISORDERS AND A PROCESS OF PREPARATION THEREOF

#763
US20250049709A1
Human necessities

ZIPRASIDONE FORMULATIONS

#764
US20250049710A1
Human necessities

AQUEOUS FORMULATIONS OF A CARDIAC P2X RECEPTOR AGONIST AND THEIR USE IN TREATING MEDICAL DISORDERS

#765
US20250049711A1
Human necessities

COMPOSITIONS COMPRISING MODIFIED PHOSPHOLIPIDS AND USES THEREOF

#766
US20250049712A1
Human necessities

HIGH-EFFICIENCY AND LOW-TOXICITY DNA AND RNA LIPID DELIVERY CARRIER

#767
US20250049713A1
Human necessities

LIPID NANOPARTICLES FOR DELIVERY OF AGENTS

#768
US20250049714A1
Human necessities

SYNTHESIS OF ESTER, CARBONATE, AND CARBAMATE-DERIVED NOVEL BIODEGRADABLE IONIZABLE LIPIDS FROM METHYL RICINOLEATE OR METHYL 12-HYDROXYSTEARATE AND ITS APPLICATIONS

#769
US20250049715A1
Human necessities

Membrane Encapsulated Nanoparticles and Method of Use

#770
US20250049716A1
Human necessities

Membrane Encapsulated Nanoparticles and Method of Use

#771
US20250049717A1
Human necessities

DRY POWDER FORMULATIONS OF NARROW SPECTRUM KINASE INHIBITORS

#772
US20250049718A1
Human necessities

NANOPARTICLES AND NANONETWORKS FORMED THEREFROM

#773
US20250049719A1
Human necessities

DEXAMETHASONE PRODRUG COMPOSITIONS AND USES THEREOF

#774
US20250049720A1
Human necessities

Method for improving the dissolution profile of a biologically active material

#775
US20250049721A1
Human necessities

Formulations of Enzalutamide

#776
US20250049722A1
Human necessities

TRIPULSE RELEASE STIMULANT FORMULATIONS

#777
US20250049723A1
Human necessities

PRECISION PHARMACEUTICAL 3D PRINTING DEVICE

#778
US20250049724A1
Human necessities

MICROCAPSULE DISPERSIONS WITH EMULSIFIER

#779
US20250049725A1
Human necessities

TWO-STAGE MICROPARTICLE-BASED THERAPEUTIC DELIVERY SYSTEM AND METHOD

#780 ✅ Patent 12,220,489 granted on 2025-02-11
US20250049726A1
Human necessities

MANGANESE-DOPED HOLLOW MESOPOROUS SILICA NANOPARTICLES LOADED WITH CURCUMIN

#781
US20250049727A1
Human necessities

COMPOSITIONS FOR THE DELIVERY OF PAYLOAD MOLECULES TO AIRWAY EPITHELIUM

#782
US20250049728A1
Human necessities

PROCESSES FOR PREPARING LIPID NANOPARTICLES

#783
US20250049729A1
Human necessities

POEGMA-BASED LIPID NANOPARTICLES

#784
US20250049730A1
Human necessities

ULTRA SMALL GELATIN NANOPARTICLES, COMPOSITE STRUCTURES AND SYNTHESIS METHOD

#785
US20250049731A1
Human necessities

DESIGNED ANTIBODY-BOUND NANOPARTICLES

#786
US20250049732A1
Human necessities

Transdermal Delivery Systems and Methods for Inhibiting, Stopping, Blocking, or Modulating Glutaminolysis, Glutamine, and Other Glutaminolysis Catalyzing Enzymes Across Multiple Metabolic Pathways in Human Beings and Animals

#787
US20250049733A1
Human necessities

PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF INFECTIOUS RESPIRATORY DISEASES CAUSED BY INFLUENZA AND SARS-COV-2, AMONG OTHERS

#788
US20250049734A1
Human necessities

EXTENDED RELEASE PHARMACEUTICAL FORMULATION

#789
US20250049735A1
Human necessities

MEDICINE FOR STEATOHEPATITIS

#790
US20250049736A1
Human necessities

SULFONAMIDE DERIVATIVES AND THEIR USE AS SOLUBLE EPOXIDE HYDROLASE INHIBITORS

#791
US20250049737A1
Human necessities

Lauflumide and derivatives thereof for treating chronic fatigue syndrome and myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS)

#792
US20250049738A1
Human necessities

METHOD OF TREATMENT AND SELECTION OF PATIENTS BENEFITING FROM AGOMELATINE BASED ON EEG MEASUREMENTS

#793 ✅ Patent 12,226,375 granted on 2025-02-18
US20250049739A1
Human necessities

Method of treatment and selection of patients benefiting from agomelatine based on EEG measurements

#794
US20250049740A1
Human necessities

COMPOUND AND USE THEREOF IN PREPARATION OF MEDICAMENT FOR TREATING ALZHEIMER'S DISEASE

#795
US20250049741A1
Human necessities

COMPOSITION FOR PREVENTING OR TREATING ALZHEIMER'S DISEASE COMPRISING PHOSPHOLIPASE C ACTIVATOR AS AN ACTIVE INGREDIENT

#796
US20250049742A1
Human necessities

TREATMENT FOR INTERSTITIAL LUNG DISEASE

#797
US20250049743A1
Human necessities

METHOD OF PRODUCING AN ORAL OSMOTIC PHARMACEUTICAL DELIVERY SYSTEM AND A PHARMACEUTICAL BATCH PRODUCED USING THE SAME

#798
US20250049744A1
Human necessities

AMINO ACID FORMULATIONS FOR THE TREATMENT OF INTESTINAL INFLAMMATION AND SYMPTOMS THEREOF

#799
US20250049745A1
Human necessities

COMPOSITION COMPRISING SHORT AND MEDIUM-CHAIN FATTY ACIDS AND ITS USE IN THE PROPHYLAXIS AND TREATMENT OF INFECTIONS

#800
US20250049746A1
Human necessities

Medicinal Oil for Reducing Gastrointestinal Reaction Caused by Sulforaphane (SFA) and Sulforaphene

#801
US20250049747A1
Human necessities

USE OF HYPERPOLARIZING AGENTS ALONE AND IN COMBINATION WITH OTHER THERAPEUTIC AGENTS FOR TREATING CANCERS INCLUDING GLIOBLASTOMA

#802
US20250049748A1
Human necessities

ANALOGS OF 4-BROMO-2,5-DIMETHOXYPHENETHYLAMINE

#803
US20250049749A1
Human necessities

COMPOSITION FOR IMPROVING SLEEP QUALITY OR CONTROLLING AUTONOMIC NERVOUS SYSTEM

#804
US20250049750A1
Human necessities

MALTODEXTRIN FORMULATIONS

#805
US20250049751A1
Human necessities

L-THEANINE AND TETRAHYDROCANNABINOL FORMULATION

#806
US20250049752A1
Human necessities

COMPOUNDS AND FORMS OF TREATMENT FOR FEMALE SEXUAL DISORDERS

#807
US20250049753A1
Human necessities

METHODS AND COMPOSITIONS FOR DELIVERING MYCOPHENOLIC ACID ACTIVE AGENTS TO NON-HUMAN MAMMALS

#808
US20250049754A1
Human necessities

COMPOSITIONS COMPRISING UROLITHIN FOR TREATING MUSCLE DECLINE AND A KIDNEY DYSFUNCTION

#809
US20250049755A1
Human necessities

Compositions and Methods for Treating Cancers of The Central Nervous System (CNS), Including Glioblastoma and Chemoresistant CNS Tumors, And Related Compositions and Methods for Inhibiting and Eliminating CNs Cancer Stem Cells

#810
US20250049756A1
Human necessities

CYCLIC NITRO COMPOUNDS, PHARMACEUTICAL COMPOSITIONS THEREOF AND USES THEREOF

#811
US20250049757A1
Human necessities

COMBINATORY THERAPY FOR CANCER USING BIPHENYL COMPOUND AND IMMUNE CHECKPOINT MOLECULE REGULATOR

#812
US20250049758A1
Human necessities

Danegaptide Formulation for Application in the Eye

#813
US20250049759A1
Human necessities

PHARMACEUTICAL PREPARATION FOR ASSISTING IN PROMOTING SLEEP AND PREPARATION METHOD THEREOF

#814 ✅ Patent 12,310,946 granted on 2025-05-27
US20250049760A1
Human necessities

Pharmaceutical composition for oral administration of edaravone and method of administering same

#815
US20250049761A1
Human necessities

COMPOSITIONS AND METHODS FOR TREATING PRESBYOPIA, MILD HYPEROPIA, AND IRREGULAR ASTIGMATISM

#816
US20250049762A1
Human necessities

COMBINATION COMPRISING A GLUCOCORTICOID AND EDO-S101

#817
US20250049763A1
Human necessities

ALDOSTERONE SYNTHASE INHIBITORS FOR TREATING CHRONIC KIDNEY DISEASE

#818
US20250049764A1
Human necessities

Compositions and Methods of Treating Cardiac Fibrosis with Ifetroban

#819
US20250049765A1
Human necessities

BICYCLO [3.2.0] HEPTANE BIS(AMIDE) RXFP1 AGONISTS

#820
US20250049766A1
Human necessities

HIGH DOSAGE TEBIPENEM PIVOXIL TABLET FORMULATION

#821
US20250049767A1
Human necessities

FORMULATIONS, METHODS, KITS, AND DOSAGE FORMS

#822
US20250049768A1
Human necessities

METHODS OF TREATING ESTROGEN RECEPTOR-ASSOCIATED DISEASES

#823 ✅ Patent 12,329,750 granted on 2025-06-17
US20250049769A1
Human necessities

TREATMENT OF MIGRAINE

#824
US20250049770A1
Human necessities

Phosphodiesterase 4 Inhibitor Decreases Thrombosis in Simulated ECMO Model

#825
US20250049771A1
Human necessities

METHOD FOR REDUCING SIDE EFFECTS FROM ADMINISTRATION OF PHOSPHODIESTERASE-4 INHIBITORS

#826
US20250049772A1
Human necessities

PIPERIDINYL-3-(ARYLOXY)PROPANAMIDES AND PROPANOATES

#827
US20250049773A1
Human necessities

INHIBITION OF STEROL RESPONSE ELEMENT BINDING PROTEINS AS ATARGET FOR SELECTIVE ELIMINATION OF SENESCENT CELLS

#828
US20250049774A1
Human necessities

Crystalline Forms of Apalutamide

#829
US20250049775A1
Human necessities

USE OF AMINOPYRAZOLE COMPOUNDS

#830
US20250049776A1
Human necessities

AUTOPHAGY INDUCING COMPOUNDS AND USES THEREOF, IN PARTICULAR FOR A SYSTEMIC TREATMENT OF DISEASES AND CONDITIONS

#831
US20250049777A1
Human necessities

PHARMACEUTICALLY ACCEPTABLE SALT AND CRYSTALLINE FORM OF GLP-1 RECEPTOR AGONIST AND PREPARATION METHOD THEREFOR

#832
US20250049778A1
Human necessities

CRYSTALLINE FORM OF GLP-1 RECEPTOR AGONIST AND PREPARATION METHOD THEREFOR

#833
US20250049779A1
Human necessities

COMBINATION OF AN A2-ADRENOCEPTOR SUBTYPE C (ALPHA-2C) ANTAGONIST WITH A NOREPINEPHRINE REUPTAKE INHIBITOR FOR THE TREATMENT OF SLEEP APNEA

#834
US20250049780A1
Human necessities

THIENOPYRROLE COMPOUNDS

#835
US20250049781A1
Human necessities

PHARMACEUTICAL COMPOSITIONS COMPRISING RPL554 IN HFA-134A FOR ADMINISTRATION BY INHALATION

#836
US20250049782A1
Human necessities

ANTIBODY-DRUG CONJUGATE

#837 ✅ Patent 12,318,379 granted on 2025-06-03
US20250049783A1
Human necessities

Opioid formulations

#838
US20250049784A1
Human necessities

METHODS OF TREATING PROSTATE CANCER OR METASTASIZED PROSTATE CANCER

#839
US20250049785A1
Human necessities

METHODS FOR THE TREATMENT OF GLIOBLASTOMA THAT MINIMIZE RADIATION DAMAGE IN SUSCEPTIBLE PATIENTS

#840
US20250049786A1
Human necessities

DOPAMINE D3/D2 RECEPTOR MODULATING COMPOUNDS

#841
US20250049787A1
Human necessities

TREATMENT FOR ACUTE MYELOID LEUKEMIA OR LYMPHOMA

#842
US20250049788A1
Human necessities

2,3-DIHYDROBENZO [B][1, 4]DIOXIN-2-YLMETHYL)PIPERAZIN-1-YL DERIVATES FOR THE TREATMENT OF SLEEP APNEA

#843
US20250049789A1
Human necessities

METHODS OF TREATING ALOPECIA ARAETA

#844
US20250049790A1
Human necessities

TREATMENT OF NEUROLOGICAL DISORDERS

#845
US20250049791A1
Human necessities

Synthesis of MEK7 Inhibitors and methods of Use Thereof

#846
US20250049792A1
Human necessities

COMBINATION THERAPY FOR TREATING ABNORMAL CELL GROWTH

#847
US20250049793A1
Human necessities

PYRAZOLE PYRIMIDINE DERIVATIVE AND USES THEREOF

#848
US20250049794A1
Human necessities

PHARMACEUTICAL FORMULATIONS OF GPR119 AGONISTS AND USES THEREOF

#849
US20250049795A1
Human necessities

USE OF 5-(2-((5-(4-(DIMETHYLAMINO)PIPERIDIN-1-YL)PYRIDIN-2-YL)AMINO)-5-FLUOROPYRIMIDIN-4-YL)-N,4-DIMETHYLTHIAZOL-2-AMINE IN COMBINATION THERAPIES FOR CANCER

#850
US20250049796A1
Human necessities

USE OF 4-THIAZOL-N-(PYRIDIN-2-YL)PYRIMIDIN-2-AMINE DERIVATIVES IN COMBINATION THERAPIES FOR CANCER

#851
US20250049797A1
Human necessities

KINASE INHIBITOR SALTS AND COMPOSITIONS THEREOF

#852
US20250049798A1
Human necessities

WEE1 PROTEIN KINASE DEGRADATION AGENT AND USE THEREOF

#853
US20250049799A1
Human necessities

Targeted Therapy of Pyrrolo[2,3-D]Pyrimidine Antifolates in a Syngeneic Mouse Model of High Grade Serous Ovarian Cancer

#854
US20250049800A1
Human necessities

VCP/p97 INHIBITOR FOR THE TREATMENT OF CANCER

#855
US20250049801A1
Human necessities

PHARMACEUTICAL COMBINATIONS FOR USE IN THE TREATMENT OF NEOPLASTIC DISEASES

#856
US20250049802A1
Human necessities

COMBINATION THERAPIES AND USES FOR TREATING CANCER

#857
US20250049803A1
Human necessities

COMBINATION OF A TASK1/3 CHANNEL BLOCKER WITH A NOREPINEPHRINE REUPTAKE INHIBITOR FOR THE TREATMENT OF SLEEP APNEA

#858
US20250049804A1
Human necessities

FERROCHELATASE INHIBITORS AND METHODS OF USE

#859
US20250049805A1
Human necessities

COMPOSITIONS CONTAINING A NON-CAFFEINE STIMULANT OR NOOTROPIC AND BETA-HYDROXYBUTYRATE OR PRECURSOR FOR INCREASING NEUROLOGICAL AND PHYSIOLOGICAL PERFORMANCE

#860
US20250049806A1
Human necessities

PHARMACEUTICAL COMPOSITION FOR PROVIDING TREATMENT FOR OR PREVENTING ALPORT SYNDROME

#861
US20250049807A1
Human necessities

COMBINATION OF CISPLATIN AND ELIMUSERTIB FOR THE TREATMENT OF PEDIATRIC LIVER CANCERS

#862
US20250049808A1
Human necessities

CRYSTALLINE FORMS OF A DEOXYCYTIDINE KINASE INHIBITOR AND USES THEREOF

#863
US20250049809A1
Human necessities

INHIBITORS OF MUTANT IDH1 AND IDH2

#864
US20250049810A1
Human necessities

METHODS OF TREATING A RAS PROTEIN-RELATED DISEASE OR DISORDER

#865
US20250049811A1
Human necessities

METHODS OF TREATING PANCREATIC CANCER BY USING BET INHIBITOR AND PARP INHIBITOR

#866
US20250049812A1
Human necessities

Compounds that Inhibit Necroptosis and Their Preparation Methods

#867
US20250049813A1
Human necessities

CERTAIN N-(1-CYAN0-2-PHENYLETHYL]-1,4-OXAZEPANE-2-CARBOXAMIDES FOR TREATING CHRONIC RHINOSINUSITIS

#868
US20250049814A1
Human necessities

5-AZAINDAZOLE DERIVATIVES AS ADENOSINE RECEPTOR ANTAGONISTS

#869
US20250049815A1
Human necessities

25-HYDROXYCHOLESTEROL (25HC), CRYAB AGGREGATION INHIBITOR TO AMELIORIATE VASCULAR STIFFNESS

#870
US20250049816A1
Human necessities

COMPOSITIONS COMPRISING THYMOQUINONE AND VITAMIN D

#871
US20250049817A1
Human necessities

JAK INHIBITOR WITH A VITAMIN D ANALOG FOR TREATMENT OF SKIN DISEASES

#872
US20250049818A1
Human necessities

PRENATAL SUPPLEMENT COMPOSITIONS FOR INCREASING BREASTMILK MICRONUTRIENT LEVELS

#873
US20250049819A1
Human necessities

METHODS FOR TREATING AND PREVENTING C. DIFFICILE INFECTION

#874
US20250049820A1
Human necessities

TETRACYCLINE COMPOSITIONS

#875
US20250049821A1
Human necessities

Pharmaceutical Composition and Method for Treating Seizure Disorders

#876
US20250049822A1
Human necessities

TREATMENT OF ADENOVIRUS INFECTION OR DISEASE ASSOCIATED WITH ADENOVIRUS INFECTION

#877
US20250049823A1
Human necessities

MITOCHONDRIAL ATP INHIBITORS TARGETING THE GAMMA SUBUNIT PREVENT METASTASIS

#878
US20250049824A1
Human necessities

STABLE PHARMACEUTICAL COMPOSITIONS OF CYCLOPHOSPHAMIDE

#879
US20250049825A1
Human necessities

Surfactant Lipids, Compositions Thereof, and Uses Thereof

#880
US20250049826A1
Human necessities

COMPOSITION FOR PROMOTING THE MATURING OF THE CENTRAL NERVOUS SYSTEM

#881
US20250049827A1
Human necessities

A PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF OTIC INFECTIONS

#882
US20250049828A1
Human necessities

PHARMACEUTICAL COMPOSITION FOR TREATING TUMORS AND USE

#883
US20250049829A1
Human necessities

NOVEL THERAPEUTIC MOLECULES TARGETING THE H-RAS ISOFORM WITH G12D MUTATION INVOLVED IN CANCER FORMATION

#884
US20250049830A1
Human necessities

PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING CANCER, COMPRISING SGLT-2 INHIBITOR AND GOSSYPOL

#885
US20250049831A1
Human necessities

ANTIVIRAL USE OF BISEPOXYLIGNAN COMPOUND, AND BISEPOXYLIGNAN COMPOSITION AND PREPARATION OF BISEPOXYLIGNAN COMPOUND

#886
US20250049832A1
Human necessities

CRYSTAL FORM OF NUCLEOSIDE COMPOUND

#887
US20250049833A1
Human necessities

ADMINISTRATION OF NICOTINAMIDE MONONUCLEOTIDE IN THE TREATMENT OF DISEASE

#888
US20250049834A1
Human necessities

Methods and Compositions for Treating Mucositis

#889
US20250049835A1
Human necessities

COMPOSITIONS FOR ALTERING CYCLIC ADP-RIBOSE SECONDARY MESSENGER SIGNALLING

#890
US20250049836A1
Human necessities

PRODRUGS OF DEOXYNUCLEOSIDES FOR TREATMENT OF MITOCHONDRIAL DISEASES CAUSED BY UNBALANCED NUCLEOTIDE POOLS

#891
US20250049837A1
Human necessities

MICRORNA-BASED PARTICLE FOR THE TREATMENT OF DYSREGULATED IMMUNE RESPONSE

#892
US20250049838A1
Human necessities

Antisense Compounds Targeting Genes Associated with Cystic Fibrosis

#893
US20250049839A1
Human necessities

COMPOSITIONS AND METHODS FOR TARGETING CELLS

#894
US20250049840A1
Human necessities

COMPOSITIONS COMPRISING A CHEMOKINE RECEPTOR PATHWAY INHIBITOR

#895
US20250049841A1
Human necessities

NITRIC OXIDE-RELEASING NASAL COMPOSITIONS AND METHODS OF USE THEREOF

#896
US20250049842A1
Human necessities

THERAPEUTIC BLOOD-ACID-SHIFTING COMPOSITIONS AND METHODS

#897
US20250049843A1
Human necessities

IRON OXIDE NANOPARTICLE-MEDIATED RADIATION DELIVERY FOR TARGETED CANCER TREATMENT

#898 ✅ Patent 12,268,711 granted on 2025-04-08
US20250049844A1
Human necessities

Methods for preparing products for treating scald infection caused by

#899
US20250049845A1
Human necessities

METHODS AND COMPOSITIONS FOR NATURAL KILLER CELLS

#900
US20250049846A1
Human necessities

METHODS AND COMPOSITIONS FOR TREATING CANCER WITH IMMUNE CELLS